Autophagy-Sirt3 axis decelerates hematopoietic aging

Area of Science:

• Hematology
• Cellular Biology
• Aging Research

Background:

• Autophagy is known to preserve hematopoietic stem cells (HSCs) in mice by suppressing mitochondrial metabolism.
• The role of autophagy in human hematopoietic aging remains largely uncharacterized.
• Reduced autophagy is increasingly linked to age-related cellular dysfunction.

Purpose of the Study:

• To investigate the mechanism by which autophagy regulates hematopoietic aging in humans.
• To explore the relationship between autophagy, Sirt3 expression, and blood rejuvenation.
• To identify potential therapeutic targets for combating age-related decline in blood cell production.

Main Methods:

• Analysis of autophagy levels in human hematopoietic cells and HSCs across different age groups.
• Investigating the regulatory link between autophagy and Sirt3 expression in mouse and human hematopoietic cells.
• Utilizing genetic manipulation (forced Sirt3 expression) in mouse models to assess its impact on hematopoietic aging.
• Validating the effect of autophagy modulation on Sirt3 expression in human HSC-enriched cells.

Main Results:

• A reduction in autophagy in human hematopoietic cells and HSCs correlates with aged hematopoiesis.
• Autophagy activation upregulates Sirt3, a mitochondrial protein crucial for blood rejuvenation.
• In mice, autophagy deficiency impairs Sirt3 expression, leading to accelerated hematopoietic aging.
• Forced Sirt3 expression in HSCs mitigates oxidative stress and prevents aging-related hematopoietic decline caused by autophagy defects.
• Autophagy-induced Sirt3 upregulation is confirmed in human HSC-enriched cells.

Conclusions:

• An autophagy-Sirt3 axis is identified as a key regulator of hematopoietic aging.
• This axis plays a critical role in maintaining blood cell function and rejuvenation.
• Targeting the autophagy-Sirt3 pathway presents a promising strategy for human blood rejuvenation interventions.